- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1433-2965
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Observations following discontinuation of long-term denosumab therapy ; day:31 ; month:1 ; year:2017 ; pages:1-10
Osteoporosis international ; (31.1.2017), 1-10
- Schlagwort
-
Orthopädie
- Urheber
-
McClung, M. R.
- Beteiligte Personen und Organisationen
-
Wagman, R. B.
Miller, P. D.
Wang, A.
Lewiecki, E. M.
SpringerLink (Online service)
- DOI
-
10.1007/s00198-017-3919-1
- URN
-
urn:nbn:de:1111-201702258207
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- McClung, M. R.
- Wagman, R. B.
- Miller, P. D.
- Wang, A.
- Lewiecki, E. M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Osteoclast Recycling and the Rebound Phenomenon Following Denosumab Discontinuation
Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study
Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study
Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy
Bone loss after denosumab discontinuation is prevented by alendronate and zoledronic acid but not risedronate: a retrospective study
Rebound activation of 5-HT neurons following SSRI discontinuation
Development of obsessive-compulsive symptoms following abrupt discontinuation of venlafaxine
Response to letter to the Editors—Safety of long-term denosumab therapy
Denosumab and muscle performance
Denosumab: A comprehensive review
Lessons learned from long-term side effects after zoledronic acid infusion following denosumab treatment: a case report and review of the literature
Monoclonal antibody desensitization in a patient with a generalized urticarial reaction following denosumab administration
Osteoclast Recycling and the Rebound Phenomenon Following Denosumab Discontinuation
Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study
Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study
Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy
Bone loss after denosumab discontinuation is prevented by alendronate and zoledronic acid but not risedronate: a retrospective study
Rebound activation of 5-HT neurons following SSRI discontinuation
Development of obsessive-compulsive symptoms following abrupt discontinuation of venlafaxine
Response to letter to the Editors—Safety of long-term denosumab therapy
Denosumab and muscle performance
Denosumab: A comprehensive review
Lessons learned from long-term side effects after zoledronic acid infusion following denosumab treatment: a case report and review of the literature
Monoclonal antibody desensitization in a patient with a generalized urticarial reaction following denosumab administration
Osteoclast Recycling and the Rebound Phenomenon Following Denosumab Discontinuation
Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study
Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study
Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy
Bone loss after denosumab discontinuation is prevented by alendronate and zoledronic acid but not risedronate: a retrospective study
Rebound activation of 5-HT neurons following SSRI discontinuation
Development of obsessive-compulsive symptoms following abrupt discontinuation of venlafaxine
Response to letter to the Editors—Safety of long-term denosumab therapy
Denosumab and muscle performance
Denosumab: A comprehensive review
Lessons learned from long-term side effects after zoledronic acid infusion following denosumab treatment: a case report and review of the literature